Versant Venture Management, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
VV Versant Venture Management, LLC | Institutional Filer | ▼ 6.39% | $141.4M | 8 |
Current Portfolio Holdings
Showing all 8 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | 3.2M | $52.3M | 37.00% |
| 2 | IPSC | Century Therapeutics, Inc. | Healthcare | 12.2M | $27.5M | 19.44% |
| 3 | LENZ | LENZ Therapeutics, Inc. | Healthcare | 2.7M | $24.3M | 17.19% |
| 4 | JBIO | Jade Biosciences, Inc. | Healthcare | 1.5M | $21.4M | 15.16% |
| 5 | CTNM | Contineum Therapeutics, Inc. Class A Common Stock | Healthcare | 543K | $7.1M | 5.01% |
| 6 | CRSP | CRISPR Therapeutics AG | Healthcare | 149K | $7.1M | 5.01% |
| 7 | SKYE | Skye Bioscience, Inc. | Healthcare | 2.0M | $1.2M | 0.87% |
| 8 | TPST | Tempest Therapeutics, Inc. | Healthcare | 270K | $442K | 0.31% |
Showing 1 to 8 of 8 holdings